Global Monoclonal Antibody Therapeutics Market Size, Status and Forecast 2025

  • receipt Report ID : 12493
  • calendar_today Published On: Jan, 2018
  • file_copy Pages: 101
  • list Healthcare
This report studies the global Monoclonal Antibody Therapeutics market, analyzes and researches the Monoclonal Antibody Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

Bayer

F. Hoffmann-La Roche

Pfizer

Sanofi

GlaxoSmithKline

Merck

Novartis

AbbVie

Amgen

Johnson & Johnson

Bristol-Myers Squibb Company

Biogen



Market segment by Regions/Countries, this report covers

United States

EU

Japan

China

India

Southeast Asia



Market segment by Type, the product can be split into

Humanized Antibody

Human Mouse Chimeric Antibody



Market segment by Application, Monoclonal Antibody Therapeutics can be split into

Cancer

Autoimmune Diseases

Infection

Hematological Diseases

Ophthalmological Diseases

Others



If you have any special requirements, please let us know and we will offer you the report as you want.





Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents



Global Monoclonal Antibody Therapeutics Market Size, Status and Forecast 2025

1 Industry Overview of Monoclonal Antibody Therapeutics

1.1 Monoclonal Antibody Therapeutics Market Overview

1.1.1 Monoclonal Antibody Therapeutics Product Scope

1.1.2 Market Status and Outlook

1.2 Global Monoclonal Antibody Therapeutics Market Size and Analysis by Regions (2013-2018)

1.2.1 United States

1.2.2 EU

1.2.3 Japan

1.2.4 China

1.2.5 India

1.2.6 Southeast Asia

1.3 Monoclonal Antibody Therapeutics Market by Type

1.3.1 Humanized Antibody

1.3.2 Human Mouse Chimeric Antibody

1.4 Monoclonal Antibody Therapeutics Market by End Users/Application

1.4.1 Cancer

1.4.2 Autoimmune Diseases

1.4.3 Infection

1.4.4 Hematological Diseases

1.4.5 Ophthalmological Diseases

1.4.6 Others



2 Global Monoclonal Antibody Therapeutics Competition Analysis by Players

2.1 Monoclonal Antibody Therapeutics Market Size (Value) by Players (2013-2018)

2.2 Competitive Status and Trend

2.2.1 Market Concentration Rate

2.2.2 Product/Service Differences

2.2.3 New Entrants

2.2.4 The Technology Trends in Future



3 Company (Top Players) Profiles

3.1 Bayer

3.1.1 Company Profile

3.1.2 Main Business/Business Overview

3.1.3 Products, Services and Solutions

3.1.4 Monoclonal Antibody Therapeutics Revenue (Million USD) (2013-2018)

3.1.5 Recent Developments

3.2 F. Hoffmann-La Roche

3.2.1 Company Profile

3.2.2 Main Business/Business Overview

3.2.3 Products, Services and Solutions

3.2.4 Monoclonal Antibody Therapeutics Revenue (Million USD) (2013-2018)

3.2.5 Recent Developments

3.3 Pfizer

3.3.1 Company Profile

3.3.2 Main Business/Business Overview

3.3.3 Products, Services and Solutions

3.3.4 Monoclonal Antibody Therapeutics Revenue (Million USD) (2013-2018)

3.3.5 Recent Developments

3.4 Sanofi

3.4.1 Company Profile

3.4.2 Main Business/Business Overview

3.4.3 Products, Services and Solutions

3.4.4 Monoclonal Antibody Therapeutics Revenue (Million USD) (2013-2018)

3.4.5 Recent Developments

3.5 GlaxoSmithKline

3.5.1 Company Profile

3.5.2 Main Business/Business Overview

3.5.3 Products, Services and Solutions

3.5.4 Monoclonal Antibody Therapeutics Revenue (Million USD) (2013-2018)

3.5.5 Recent Developments

3.6 Merck

3.6.1 Company Profile

3.6.2 Main Business/Business Overview

3.6.3 Products, Services and Solutions

3.6.4 Monoclonal Antibody Therapeutics Revenue (Million USD) (2013-2018)

3.6.5 Recent Developments

3.7 Novartis

3.7.1 Company Profile

3.7.2 Main Business/Business Overview

3.7.3 Products, Services and Solutions

3.7.4 Monoclonal Antibody Therapeutics Revenue (Million USD) (2013-2018)

3.7.5 Recent Developments

3.8 AbbVie

3.8.1 Company Profile

3.8.2 Main Business/Business Overview

3.8.3 Products, Services and Solutions

3.8.4 Monoclonal Antibody Therapeutics Revenue (Million USD) (2013-2018)

3.8.5 Recent Developments

3.9 Amgen

3.9.1 Company Profile

3.9.2 Main Business/Business Overview

3.9.3 Products, Services and Solutions

3.9.4 Monoclonal Antibody Therapeutics Revenue (Million USD) (2013-2018)

3.9.5 Recent Developments

3.10 Johnson & Johnson

3.10.1 Company Profile

3.10.2 Main Business/Business Overview

3.10.3 Products, Services and Solutions

3.10.4 Monoclonal Antibody Therapeutics Revenue (Million USD) (2013-2018)

3.10.5 Recent Developments

3.11 Bristol-Myers Squibb Company

3.12 Biogen



4 Global Monoclonal Antibody Therapeutics Market Size by Type and Application (2013-2018)

4.1 Global Monoclonal Antibody Therapeutics Market Size by Type (2013-2018)

4.2 Global Monoclonal Antibody Therapeutics Market Size by Application (2013-2018)

4.3 Potential Application of Monoclonal Antibody Therapeutics in Future

4.4 Top Consumer/End Users of Monoclonal Antibody Therapeutics



5 United States Monoclonal Antibody Therapeutics Development Status and Outlook

5.1 United States Monoclonal Antibody Therapeutics Market Size (2013-2018)

5.2 United States Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2013-2018)

5.3 United States Monoclonal Antibody Therapeutics Market Size by Application (2013-2018)



6 EU Monoclonal Antibody Therapeutics Development Status and Outlook

6.1 EU Monoclonal Antibody Therapeutics Market Size (2013-2018)

6.2 EU Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2013-2018)

6.3 EU Monoclonal Antibody Therapeutics Market Size by Application (2013-2018)



7 Japan Monoclonal Antibody Therapeutics Development Status and Outlook

7.1 Japan Monoclonal Antibody Therapeutics Market Size (2013-2018)

7.2 Japan Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2013-2018)

7.3 Japan Monoclonal Antibody Therapeutics Market Size by Application (2013-2018)



8 China Monoclonal Antibody Therapeutics Development Status and Outlook

8.1 China Monoclonal Antibody Therapeutics Market Size (2013-2018)

8.2 China Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2013-2018)

8.3 China Monoclonal Antibody Therapeutics Market Size by Application (2013-2018)



9 India Monoclonal Antibody Therapeutics Development Status and Outlook

9.1 India Monoclonal Antibody Therapeutics Market Size (2013-2018)

9.2 India Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2013-2018)

9.3 India Monoclonal Antibody Therapeutics Market Size by Application (2013-2018)



10 Southeast Asia Monoclonal Antibody Therapeutics Development Status and Outlook

10.1 Southeast Asia Monoclonal Antibody Therapeutics Market Size (2013-2018)

10.2 Southeast Asia Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2013-2018)

10.3 Southeast Asia Monoclonal Antibody Therapeutics Market Size by Application (2013-2018)



11 Market Forecast by Regions, Type and Application (2018-2025)

11.1 Global Monoclonal Antibody Therapeutics Market Size (Value) by Regions (2018-2025)

11.1.1 United States Monoclonal Antibody Therapeutics Revenue and Growth Rate (2018-2025)

11.1.2 EU Monoclonal Antibody Therapeutics Revenue and Growth Rate (2018-2025)

11.1.3 Japan Monoclonal Antibody Therapeutics Revenue and Growth Rate (2018-2025)

11.1.4 China Monoclonal Antibody Therapeutics Revenue and Growth Rate (2018-2025)

11.1.5 India Monoclonal Antibody Therapeutics Revenue and Growth Rate (2018-2025)

11.1.6 Southeast Asia Monoclonal Antibody Therapeutics Revenue and Growth Rate (2018-2025)

11.2 Global Monoclonal Antibody Therapeutics Market Size (Value) by Type (2018-2025)

11.3 Global Monoclonal Antibody Therapeutics Market Size by Application (2018-2025)



12 Monoclonal Antibody Therapeutics Market Dynamics

12.1 Monoclonal Antibody Therapeutics Market Opportunities

12.2 Monoclonal Antibody Therapeutics Challenge and Risk

12.2.1 Competition from Opponents

12.2.2 Downside Risks of Economy

12.3 Monoclonal Antibody Therapeutics Market Constraints and Threat

12.3.1 Threat from Substitute

12.3.2 Government Policy

12.3.3 Technology Risks

12.4 Monoclonal Antibody Therapeutics Market Driving Force

12.4.1 Growing Demand from Emerging Markets

12.4.2 Potential Application



13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs Trend/Customer Preference

13.3 External Environmental Change

13.3.1 Economic Fluctuations

13.3.2 Other Risk Factors



14 Research Finding/Conclusion



15 Appendix

Methodology

Analyst Introduction

Data Source





1

Please fill the form below, to recieve the report sample


+1